ROCHESTER, N.Y. — PharmaSmart International Inc. will roll out health screening kiosks (model PS2000) at Schnuck Markets in-store pharmacies.
Schnucks intends to leverage PharmaSmart’s clinical-grade program to drive Medicare Star Ratings objectives, specifically measuring D-14 (medication adherence for hypertension), and C-19 (controlling blood pressure), both of which are triple-weighted measures of high interest to national and regional insurers. Commercial plans also stand to benefit as they seek to improve cardiovascular outcomes through the reduction of long-term risk factors such as hypertension.
Bob Buganski, senior director of pharmacy at Schnucks, stated, “This is more than Schnucks just deploying new kiosks. PharmaSmart’s health screening kiosks and integrated BPT Rx solutions are a game changer for disease management at the pharmacist point of care. With the PharmaSmart program, Schnucks now offers our patients a health screening program backed by clinical evidence, and one that incorporates full integration into our Rx software, McKesson CPS. This fluid work flow integration allows us to easily intervene in cases where blood pressure control is not achieved, which is a capability our pharmacists have never had before. We will also have the data to demonstrate our impact on blood pressure control rates over a managed population.”
PharmaSmart president and CEO Fred Sarkis stated, “Those who question a pharmacists’ value in health care need to think twice. When you thoughtfully incorporate the right technology into professional work flow, and it meets published clinical standards, you earn the trust of pharmacists, and you see better execution rates at point of care. We are thrilled to be working with Schnucks pharmacists, and we look forward to supporting their team as they optimize the delivery of health care services across their stores.”